<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33398779</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.</ArticleTitle><Pagination><StartPage>2693</StartPage><EndPage>2719</EndPage><MedlinePgn>2693-2719</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-020-00429-w</ELocationID><Abstract><AbstractText>While C9orf72-specific imaging signatures have been proposed by both ALS and FTD research groups and considerable presymptomatic alterations have also been confirmed in young mutation carriers, considerable inconsistencies exist in the literature. Accordingly, a systematic review of C9orf72-imaging studies has been performed to identify consensus findings, stereotyped shortcomings, and unique contributions to outline future directions. A formal literature review was conducted according to the STROBE guidelines. All identified papers were individually reviewed for sample size, choice of controls, study design, imaging modalities, statistical models, clinical profiling, and identified genotype-associated pathological patterns. A total of 74 imaging papers were systematically reviewed. ALS patients with GGGGCC repeat expansions exhibit relatively limited motor cortex involvement and widespread extra-motor pathology. C9orf72 positive FTD patients often show preferential posterior involvement. Reports of thalamic involvement are relatively consistent across the various phenotypes. Asymptomatic hexanucleotide repeat carriers often exhibit structural and functional changes decades prior to symptom onset. Common shortcomings included sample size limitations, lack of disease-controls, limited clinical profiling, lack of genetic testing in healthy controls, and absence of post mortem validation. There is a striking paucity of longitudinal studies and existing presymptomatic studies have not evaluated the predictive value of radiological changes with regard to age of onset and phenoconversion. With the advent of antisense oligonucleotide therapies, the meticulous characterisation of C9orf72-associated changes has gained practical relevance. Neuroimaging offers non-invasive biomarkers for future clinical trials, presymptomatic ascertainment, diagnostic and prognostic applications.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li Hi Shing</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKenna</LastName><ForeName>Mary Clare</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siah</LastName><ForeName>We Fong</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chipika</LastName><ForeName>Rangariroyashe H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bede</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0492-4772</Identifier><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. bedep@tcd.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HRB EIA 2017-019</GrantID><Acronym>HRBI_</Acronym><Agency>Health Research Board</Agency><Country>Ireland</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33398779</ArticleId><ArticleId IdType="doi">10.1007/s11682-020-00429-w</ArticleId><ArticleId IdType="pii">10.1007/s11682-020-00429-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abidi, M., de Marco, G., Couillandre, A., Feron, M., Mseddi, E., Termoz, N., ... Bede, P. (2019). Adaptive functional reorganization in amyotrophic lateral sclerosis: Coexisting degenerative and compensatory changes. European Journal of Neurology. https://doi.org/10.1111/ene.14042 .</Citation></Reference><Reference><Citation>Abidi, M., de Marco, G., Grami, F., Termoz, N., Couillandre, A., Querin, G., ... Pradat, P, F. (2020). Neural correlates of motor imagery of gait in Amyotrophic Lateral Sclerosis. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.27335 .</Citation></Reference><Reference><Citation>Agosta, F., Ferraro, P. M., Riva, N., Spinelli, E. G., Chio, A., Canu, E., et al. (2016). Structural brain correlates of cognitive and behavioral impairment in MND. Human Brain Mapping, 37(4), 1614&#x2013;1626. https://doi.org/10.1002/hbm.23124 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23124</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId><ArticleId IdType="pmc">6867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta, F., Ferraro, P. M., Riva, N., Spinelli, E. G., Domi, T., Carrera, P., et al. (2017). Structural and functional brain signatures of C9orf72 in motor neuron disease. Neurobiology of Aging, 57, 206&#x2013;219. https://doi.org/10.1016/j.neurobiolaging.2017.05.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.05.024</ArticleId><ArticleId IdType="pubmed">28666709</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta, F., Spinelli, E. G., &amp; Filippi, M. (2018). Neuroimaging in amyotrophic lateral sclerosis: Current and emerging uses. Expert Review of Neurotherapeutics, 18(5), 395&#x2013;406. https://doi.org/10.1080/14737175.2018.1463160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1463160</ArticleId><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., et al. (2011). p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathologica, 122(6), 691&#x2013;702. https://doi.org/10.1007/s00401-011-0911-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameur, F., Colliot, O., Caroppo, P., Stroer, S., Dormont, D., Brice, A., et al. (2016). White matter lesions in FTLD: Distinct phenotypes characterize GRN and C9ORF72 mutations. Neurol Genet, 2(1), e47. https://doi.org/10.1212/nxg.0000000000000047 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxg.0000000000000047</ArticleId><ArticleId IdType="pubmed">27066584</ArticleId><ArticleId IdType="pmc">4817905</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo, E. M., Landeau, B., La Joie, R., Mevel, K., Mezenge, F., Perrotin, A., et al. (2013). Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders. Neuroimage, 83, 450&#x2013;457. https://doi.org/10.1016/j.neuroimage.2013.06.053 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.06.053</ArticleId><ArticleId IdType="pubmed">23796547</ArticleId></ArticleIdList></Reference><Reference><Citation>Baborie, A., Griffiths, T. D., Jaros, E., Perry, R., McKeith, I. G., Burn, D. J., et al. (2015). Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathology and Applied Neurobiology, 41(5), 601&#x2013;612. https://doi.org/10.1111/nan.12178 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12178</ArticleId><ArticleId IdType="pubmed">25185840</ArticleId><ArticleId IdType="pmc">4934135</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra, R., &amp; Isaacs, A. M. (2018). C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nature Reviews. Neurology, 14(9), 544&#x2013;558. https://doi.org/10.1038/s41582-018-0047-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId><ArticleId IdType="pmc">6417666</ArticleId></ArticleIdList></Reference><Reference><Citation>Barritt, A. W., Gabel, M. C., Cercignani, M., &amp; Leigh, P. N. (2018). Emerging magnetic resonance imaging techniques and analysis methods in Amyotrophic Lateral Sclerosis. Frontiers in Neurology, 9, 1065. https://doi.org/10.3389/fneur.2018.01065 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01065</ArticleId><ArticleId IdType="pubmed">30564192</ArticleId><ArticleId IdType="pmc">6288229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., &amp; Hardiman, O. (2018). Longitudinal structural changes in ALS: A three time-point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener, 19(3&#x2013;4), 232&#x2013;241. https://doi.org/10.1080/21678421.2017.1407795 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1407795</ArticleId><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Bokde, A. L., Byrne, S., Elamin, M., Fagan, A. J., &amp; Hardiman, O. (2012). Spinal cord markers in ALS: Diagnostic and biomarker considerations. Amyotrophic Lateral Sclerosis, 13(5), 407&#x2013;415. https://doi.org/10.3109/17482968.2011.649760 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.649760</ArticleId><ArticleId IdType="pubmed">22329869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Bokde, A. L., Byrne, S., Elamin, M., McLaughlin, R. L., Kenna, K., et al. (2013a). Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology, 81(4), 361&#x2013;369. https://doi.org/10.1212/WNL.0b013e31829c5eee .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5eee</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId><ArticleId IdType="pmc">3772833</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Elamin, M., Byrne, S., McLaughlin, R. L., Kenna, K., Vajda, A., et al. (2013b). Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology, 81(24), 2107&#x2013;2115. https://doi.org/10.1212/01.wnl.0000437313.80913.2c .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000437313.80913.2c</ArticleId><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Elamin, M., Byrne, S., McLaughlin, R. L., Kenna, K., Vajda, A., et al. (2015). Patterns of cerebral and cerebellar white matter degeneration in ALS. Journal of Neurology, Neurosurgery, and Psychiatry, 86(4), 468&#x2013;470. https://doi.org/10.1136/jnnp-2014-308172 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308172</ArticleId><ArticleId IdType="pubmed">25053771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Omer, T., Finegan, E., Chipika, R. H., Iyer, P. M., Doherty, M. A., et al. (2018b). Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: A multimodal neuroimaging study. Brain Imaging and Behavior, 12(6), 1696&#x2013;1707. https://doi.org/10.1007/s11682-018-9837-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9837-9</ArticleId><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Querin, G., &amp; Pradat, P. F. (2018c). The changing landscape of motor neuron disease imaging: The transition from descriptive studies to precision clinical tools. Current Opinion in Neurology, 31(4), 431&#x2013;438. https://doi.org/10.1097/wco.0000000000000569 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000569</ArticleId><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Chipika, R. H., Finegan, E., Li Hi Shing, S., Doherty, M. A., Hengeveld, J. C., et al. (2019). Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. Neuroimage Clin, 24, 102054. https://doi.org/10.1016/j.nicl.2019.102054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102054</ArticleId><ArticleId IdType="pubmed">31711033</ArticleId><ArticleId IdType="pmc">6849418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Chipika, R. H., Finegan, E., Li Hi Shing, S., Chang, K. M., Doherty, M. A., et al. (2020a). Progressive brainstem pathology in motor neuron diseases: Imaging data from amyotrophic lateral sclerosis and primary lateral sclerosis. Data in Brief, 29, 105229. https://doi.org/10.1016/j.dib.2020.105229 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2020.105229</ArticleId><ArticleId IdType="pubmed">32083157</ArticleId><ArticleId IdType="pmc">7016370</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede, P., Siah, W. F., McKenna, M. C., &amp; Li Hi Shing, S. (2020b). Consideration of C9orf72-associated ALS-FTD as a neurodevelopmental disorder: Insights from neuroimaging. Journal of Neurology, Neurosurgery, and Psychiatry. https://doi.org/10.1136/jnnp-2020-324416 .</Citation></Reference><Reference><Citation>Benatar, M., &amp; Wuu, J. (2012). Presymptomatic studies in ALS: Rationale, challenges, and approach. Neurology, 79(16), 1732&#x2013;1739. https://doi.org/10.1212/WNL.0b013e31826e9b1d .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826e9b1d</ArticleId><ArticleId IdType="pubmed">23071166</ArticleId><ArticleId IdType="pmc">3468777</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M., Stanislaw, C., Reyes, E., Hussain, S., Cooley, A., Fernandez, M. C., et al. (2016). Presymptomatic ALS genetic counseling and testing: Experience and recommendations. Neurology, 86(24), 2295&#x2013;2302. https://doi.org/10.1212/WNL.0000000000002773 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002773</ArticleId><ArticleId IdType="pubmed">27194384</ArticleId><ArticleId IdType="pmc">4909562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand, A., Wen, J., Rinaldi, D., Houot, M., Sayah, S., Camuzat, A., et al. (2018). Early cognitive, structural, and microstructural changes in Presymptomatic C9orf72 carriers younger than 40 years. JAMA Neurology, 75(2), 236&#x2013;245. https://doi.org/10.1001/jamaneurol.2017.4266 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4266</ArticleId><ArticleId IdType="pubmed">29197216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevan-Jones, R. W., Cope, T. E., Jones, S. P., Passamonti, L., Hong, Y. T., Fryer, T., et al. (2018). [(18)F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion. Annals of Clinical Translational Neurology, 5(10), 1292&#x2013;1296. https://doi.org/10.1002/acn3.631 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.631</ArticleId><ArticleId IdType="pubmed">30349864</ArticleId><ArticleId IdType="pmc">6186940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio, E. H., Weintraub, S., Rademakers, R., Baker, M., Ahmadian, S. S., Rademaker, A., et al. (2013). Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: Clinicopathologic correlation. Neuropathology, 33(2), 122&#x2013;133. https://doi.org/10.1111/j.1440-1789.2012.01332.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2012.01332.x</ArticleId><ArticleId IdType="pubmed">22702520</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco, H., Patin, F., Descat, A., Garcon, G., Corcia, P., Gele, P., et al. (2018). A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLoS One, 13(6), e0198116. https://doi.org/10.1371/journal.pone.0198116 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198116</ArticleId><ArticleId IdType="pubmed">29870556</ArticleId><ArticleId IdType="pmc">5988280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Gordon, E., Manning, E., Barnes, J., Cash, D. M., Espak, M., et al. (2015). Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia. Journal of Neurology, 262(12), 2635&#x2013;2642. https://doi.org/10.1007/s00415-015-7885-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7885-2</ArticleId><ArticleId IdType="pubmed">26338813</ArticleId><ArticleId IdType="pmc">4655011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Cardoso, M. J., Cash, D. M., Ourselin, S., Warren, J. D., &amp; Rohrer, J. D. (2016). Patterns of regional cerebellar atrophy in genetic frontotemporal dementia. Neuroimage Clin, 11, 287&#x2013;290. https://doi.org/10.1016/j.nicl.2016.02.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.02.008</ArticleId><ArticleId IdType="pubmed">26977398</ArticleId><ArticleId IdType="pmc">4781923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Gordon, E., Cardoso, M. J., Modat, M., Ourselin, S., Warren, J. D., &amp; Rohrer, J. D. (2018a). Thalamic atrophy in frontotemporal dementia - not just a C9orf72 problem. Neuroimage Clin, 18, 675&#x2013;681. https://doi.org/10.1016/j.nicl.2018.02.019 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.02.019</ArticleId><ArticleId IdType="pubmed">29876259</ArticleId><ArticleId IdType="pmc">5988457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Iglesias, J. E., Scelsi, M. A., Cash, D. M., Cardoso, M. J., Modat, M., et al. (2018b). Hippocampal subfield Volumetry: Differential pattern of atrophy in different forms of Genetic frontotemporal dementia. Journal of Alzheimer's Disease, 64(2), 497&#x2013;504. https://doi.org/10.3233/jad-180195 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-180195</ArticleId><ArticleId IdType="pubmed">29889066</ArticleId><ArticleId IdType="pmc">6027942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Iglesias, J. E., Cash, D. M., Warren, J. D., &amp; Rohrer, J. D. (2019). Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia. Alzheimers Dement (Amst), 11, 136&#x2013;141. https://doi.org/10.1016/j.dadm.2018.12.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.12.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta, M., Iglesias, J. E., Neason, M., Cash, D. M., Warren, J. D., &amp; Rohrer, J. D. (2020). Thalamic nuclei in frontotemporal dementia: Mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72. Human Brain Mapping, 41(4), 1006&#x2013;1016. https://doi.org/10.1002/hbm.24856 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24856</ArticleId><ArticleId IdType="pubmed">31696638</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve, B. F., Boylan, K. B., Graff-Radford, N. R., DeJesus-Hernandez, M., Knopman, D. S., Pedraza, O., et al. (2012). Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain, 135(Pt 3), 765&#x2013;783. https://doi.org/10.1093/brain/aws004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId><ArticleId IdType="pmc">3286335</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., &amp; Del Tredici, K. (2013). Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nature Reviews. Neurology, 9(12), 708&#x2013;714. https://doi.org/10.1038/nrneurol.2013.221 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId><ArticleId IdType="pmc">3943211</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., et al. (2013). Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Annals of Neurology, 74(1), 20&#x2013;38. https://doi.org/10.1002/ana.23937 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId><ArticleId IdType="pmc">3785076</ArticleId></ArticleIdList></Reference><Reference><Citation>Broad, R. J., Gabel, M. C., Dowell, N. G., Schwartzman, D. J., Seth, A. K., Zhang, H., et al. (2019). Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. Journal of Neurology, Neurosurgery, and Psychiatry, 90(4), 404&#x2013;411. https://doi.org/10.1136/jnnp-2018-318830 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318830</ArticleId><ArticleId IdType="pubmed">30361295</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke, T., Pinto-Grau, M., Lonergan, K., Elamin, M., Bede, P., Costello, E., et al. (2016). Measurement of social cognition in Amyotrophic Lateral Sclerosis: A population based Study. PLoS One, 11(8), e0160850. https://doi.org/10.1371/journal.pone.0160850 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0160850</ArticleId><ArticleId IdType="pubmed">27556398</ArticleId><ArticleId IdType="pmc">4996502</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke, T., Pinto-Grau, M., Lonergan, K., Bede, P., O'Sullivan, M., Heverin, M., et al. (2017). A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: Subphenotypes, staging, cognitive predictors, and survival. Annals of Clinical Translational Neurology, 4(5), 305&#x2013;317. https://doi.org/10.1002/acn3.407 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.407</ArticleId><ArticleId IdType="pubmed">28491898</ArticleId><ArticleId IdType="pmc">5420811</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne, S., Bede, P., Elamin, M., Kenna, K., Lynch, C., McLaughlin, R., &amp; Hardiman, O. (2011). Proposed criteria for familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(3), 157&#x2013;159. https://doi.org/10.3109/17482968.2010.545420 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.545420</ArticleId><ArticleId IdType="pubmed">21208036</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne, S., Elamin, M., Bede, P., &amp; Hardiman, O. (2012a). Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. Journal of Neurology, Neurosurgery, and Psychiatry, 83(4), 365&#x2013;367. https://doi.org/10.1136/jnnp-2011-301530 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301530</ArticleId><ArticleId IdType="pubmed">22399794</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., et al. (2012b). Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurology, 11(3), 232&#x2013;240. https://doi.org/10.1016/S1474-4422(12)70014-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId><ArticleId IdType="pmc">3315021</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne, S., Heverin, M., Elamin, M., Walsh, C., &amp; Hardiman, O. (2013). Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. https://doi.org/10.3109/21678421.2013.838586 .</Citation></Reference><Reference><Citation>Cardenas, A. M., Sarlls, J. E., Kwan, J. Y., Bageac, D., Gala, Z. S., Danielian, L. E., et al. (2017). Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study. Neuroimage Clin, 15, 200&#x2013;208. https://doi.org/10.1016/j.nicl.2017.04.024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.04.024</ArticleId><ArticleId IdType="pubmed">28529876</ArticleId><ArticleId IdType="pmc">5429246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash, D. M., Bocchetta, M., Thomas, D. L., Dick, K. M., van Swieten, J. C., Borroni, B., et al. (2018). Patterns of gray matter atrophy in genetic frontotemporal dementia: Results from the GENFI study. Neurobiology of Aging, 62, 191&#x2013;196. https://doi.org/10.1016/j.neurobiolaging.2017.10.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.10.008</ArticleId><ArticleId IdType="pubmed">29172163</ArticleId><ArticleId IdType="pmc">5759893</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelnovo, V., Caminiti, S. P., Riva, N., Magnani, G., Silani, V., &amp; Perani, D. (2019). Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation. Neurological Sciences, 40(3), 515&#x2013;521. https://doi.org/10.1007/s10072-018-3685-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3685-7</ArticleId><ArticleId IdType="pubmed">30554355</ArticleId></ArticleIdList></Reference><Reference><Citation>Caverzasi, E., Battistella, G., Chu, S. A., Rosen, H., Zanto, T. P., Karydas, A., et al. (2019). Gyrification abnormalities in presymptomatic c9orf72 expansion carriers. Journal of Neurology, Neurosurgery, and Psychiatry, 90(9), 1005&#x2013;1010. https://doi.org/10.1136/jnnp-2018-320265 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320265</ArticleId><ArticleId IdType="pubmed">31079065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., &amp; Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study group (phase III). Journal of the Neurological Sciences, 169(1&#x2013;2), 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika, R. H., Christidi, F., Finegan, E., Li Hi Shing, S., McKenna, M. C., Chang, K. M., et al. (2020a). Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis. Journal of the Neurological Sciences, 117039. https://doi.org/10.1016/j.jns.2020.117039 .</Citation></Reference><Reference><Citation>Chipika, R, H., Finegan, E., Shing, S, L, H., McKenna, M, C., Christidi, F., Chang, K, M., et al. (2020b). &#x201c;Switchboard&#x201d; malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. 27:102300. https://doi.org/10.1016/j.nicl.2020.102300 .</Citation></Reference><Reference><Citation>Chipika, R, H., Siah, W, F., McKenna, M, C., Li Hi Shing, S., Hardiman, O., &amp; Bede, P. (2020c). The presymptomatic phase of amyotrophic lateral sclerosis: Are we merely scratching the surface? Journal of Neurology. https://doi.org/10.1007/s00415-020-10289-5 .</Citation></Reference><Reference><Citation>Chipika, R, H., Siah, W, F., Shing, S, L, H., Finegan, E., McKenna, M, C., Christidi, F., ... Bede, P. (2020d). MRI data confirm the selective involvement of thalamic and amygdalar nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Data in Brief, 106246. https://doi.org/10.1016/j.dib.2020.106246 .</Citation></Reference><Reference><Citation>Christidi, F., Karavasilis, E., Zalonis, I., Ferentinos, P., Giavri, Z., Wilde, E. A., et al. (2017). Memory-related white matter tract integrity in amyotrophic lateral sclerosis: An advanced neuroimaging and neuropsychological study. Neurobiology of Aging, 49, 69&#x2013;78. https://doi.org/10.1016/j.neurobiolaging.2016.09.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.09.014</ArticleId><ArticleId IdType="pubmed">27776264</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi, F., Karavasilis, E., Rentzos, M., Kelekis, N., Evdokimidis, I., &amp; Bede, P. (2018). Clinical and radiological markers of extra-motor deficits in Amyotrophic Lateral Sclerosis. Frontiers in Neurology, 9, 1005. https://doi.org/10.3389/fneur.2018.01005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01005</ArticleId><ArticleId IdType="pubmed">30524366</ArticleId><ArticleId IdType="pmc">6262087</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi, F., Karavasilis, E., Rentzos, M., Velonakis, G., Zouvelou, V., Xirou, S., et al. (2019). Hippocampal pathology in amyotrophic lateral sclerosis: Selective vulnerability of subfields and their associated projections. Neurobiology of Aging, 84, 178&#x2013;188. https://doi.org/10.1016/j.neurobiolaging.2019.07.019 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.07.019</ArticleId><ArticleId IdType="pubmed">31629116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro, A., Pagani, M., Montuschi, A., Calvo, A., Moglia, C., Canosa, A., et al. (2014). The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. European Journal of Nuclear Medicine and Molecular Imaging, 41(5), 844&#x2013;852. https://doi.org/10.1007/s00259-013-2667-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni, M., Dalla Bella, E., Nigri, A., Pinardi, C., Demichelis, G., Porcu, L., et al. (2019). Cognitive syndromes and C9orf72 mutation are not related to cerebellar degeneration in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience, 13, 440. https://doi.org/10.3389/fnins.2019.00440 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00440</ArticleId><ArticleId IdType="pubmed">31133784</ArticleId><ArticleId IdType="pmc">6524613</ArticleId></ArticleIdList></Reference><Reference><Citation>Convery, R. S., Neason, M. R., Cash, D. M., Cardoso, M. J., Modat, M., Ourselin, S., et al. (2020). Basal forebrain atrophy in frontotemporal dementia. Neuroimage Clin, 26, 102210. https://doi.org/10.1016/j.nicl.2020.102210 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102210</ArticleId><ArticleId IdType="pubmed">32143137</ArticleId><ArticleId IdType="pmc">7058403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock, J., Hewitt, C., Highley, J. R., Brockington, A., Milano, A., Man, S., et al. (2012). Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain, 135(Pt 3), 751&#x2013;764. https://doi.org/10.1093/brain/awr365 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId><ArticleId IdType="pmc">3286332</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts, M., Gijselinck, I., Van Langenhove, T., van der Zee, J., &amp; Van Broeckhoven, C. (2013). Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends in Neurosciences, 36(8), 450&#x2013;459. https://doi.org/10.1016/j.tins.2013.04.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.04.010</ArticleId><ArticleId IdType="pubmed">23746459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cury, C., Durrleman, S., Cash, D. M., Lorenzi, M., Nicholas, J. M., Bocchetta, M., et al. (2019). Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort. Neuroimage, 188, 282&#x2013;290. https://doi.org/10.1016/j.neuroimage.2018.11.063 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.11.063</ArticleId><ArticleId IdType="pubmed">30529631</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vocht, J., Blommaert, J., Devrome, M., Radwan, A., Van Weehaeghe, D., De Schaepdryver, M., ... Van Damme, P. (2020). Use of multimodal imaging and clinical biomarkers in Presymptomatic carriers of C9orf72 repeat expansion. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2020.1087 .</Citation></Reference><Reference><Citation>DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72(2), 245&#x2013;256. https://doi.org/10.1016/j.neuron.2011.09.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez, M., Finch, N. A., Wang, X., Gendron, T. F., Bieniek, K. F., Heckman, M. G., et al. (2017). In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers. Acta Neuropathologica, 134(2), 255&#x2013;269. https://doi.org/10.1007/s00401-017-1725-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1725-7</ArticleId><ArticleId IdType="pubmed">28508101</ArticleId><ArticleId IdType="pmc">5508036</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney, E., Hornberger, M., Irish, M., Mioshi, E., Burrell, J., Tan, R., et al. (2014). Frontotemporal dementia associated with the C9ORF72 mutation: A unique clinical profile. JAMA Neurology, 71(3), 331&#x2013;339. https://doi.org/10.1001/jamaneurol.2013.6002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6002</ArticleId><ArticleId IdType="pubmed">24445580</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney, E. M., Landin-Romero, R., Irish, M., Hornberger, M., Mioshi, E., Halliday, G. M., et al. (2017). The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. Neuroimage Clin, 13, 439&#x2013;445. https://doi.org/10.1016/j.nicl.2016.11.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.11.028</ArticleId><ArticleId IdType="pubmed">28116236</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney, E. M., Ahmed, R. M., Halliday, G., Piguet, O., Kiernan, M. C., &amp; Hodges, J. R. (2018). Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members. Neurology, 91(16), e1498&#x2013;e1507. https://doi.org/10.1212/wnl.0000000000006344 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000006344</ArticleId><ArticleId IdType="pubmed">30258023</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos, D., Moreau, C., Kyheng, M., Garcon, G., Rolland, A. S., Blasco, H., et al. (2019). A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports, 9(1), 2918. https://doi.org/10.1038/s41598-019-39739-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39739-5</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId><ArticleId IdType="pmc">6393674</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl-Schmid, J., Licata, A., Goldhardt, O., Forstl, H., Yakushew, I., Otto, M., et al. (2019). FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations. Translational Psychiatry, 9(1), 54. https://doi.org/10.1038/s41398-019-0381-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0381-1</ArticleId><ArticleId IdType="pubmed">30705258</ArticleId><ArticleId IdType="pmc">6355852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukic, S., McMackin, R., Buxo, T., Fasano, A., Chipika, R., Pinto-Grau, M., et al. (2019). Patterned functional network disruption in amyotrophic lateral sclerosis. Human Brain Mapping, 40(16), 4827&#x2013;4842. https://doi.org/10.1002/hbm.24740 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24740</ArticleId><ArticleId IdType="pubmed">31348605</ArticleId><ArticleId IdType="pmc">6852475</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili, M. M., Querin, G., Bede, P., &amp; Pradat, P. F. (2019). Spinal cord imaging in Amyotrophic Lateral Sclerosis: Historical concepts-novel techniques. Frontiers in Neurology, 10, 350. https://doi.org/10.3389/fneur.2019.00350 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00350</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId><ArticleId IdType="pmc">6474186</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin, M., Pinto-Grau, M., Burke, T., Bede, P., Rooney, J., O'Sullivan, M., et al. (2017). Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener, 18(1&#x2013;2), 68&#x2013;73. https://doi.org/10.1080/21678421.2016.1248976 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1248976</ArticleId><ArticleId IdType="pubmed">27894191</ArticleId></ArticleIdList></Reference><Reference><Citation>Feis, R. A., Bouts, M., de Vos, F., Schouten, T. M., Panman, J. L., Jiskoot, L. C., et al. (2019a). A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers. Journal of Neurology, Neurosurgery, and Psychiatry. https://doi.org/10.1136/jnnp-2019-320774 .</Citation></Reference><Reference><Citation>Feis, R, A., Bouts, M., Panman, J, L., Jiskoot, L, C., Dopper, E, G, P., Schouten, T, M., ... Rombouts, S. (2019b). Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. Neuroimage Clin, 101718. https://doi.org/10.1016/j.nicl.2019.101718 .</Citation></Reference><Reference><Citation>Finegan, E., Chipika, R. H., Li Hi Shing, S., Doherty, M. A., Hengeveld, J. C., Vajda, A., et al. (2019a). The clinical and radiological profile of primary lateral sclerosis: A population-based study. Journal of Neurology, 266(11), 2718&#x2013;2733. https://doi.org/10.1007/s00415-019-09473-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09473-z</ArticleId><ArticleId IdType="pubmed">31325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan, E., Chipika, R. H., Shing, S. L. H., Hardiman, O., &amp; Bede, P. (2019b). Primary lateral sclerosis: A distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener, 20(3&#x2013;4), 133&#x2013;145. https://doi.org/10.1080/21678421.2018.1550518 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550518</ArticleId><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan, E., Li Hi Shing, S., Chipika, R. H., Doherty, M. A., Hengeveld, J. C., Vajda, A., et al. (2019c). Widespread subcortical grey matter degeneration in primary lateral sclerosis: A multimodal imaging study with genetic profiling. Neuroimage Clin, 24, 102089. https://doi.org/10.1016/j.nicl.2019.102089 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102089</ArticleId><ArticleId IdType="pubmed">31795059</ArticleId><ArticleId IdType="pmc">6978214</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter, M. K., Bageac, D., Danielian, L. E., Braun, L. E., Traynor, B. J., &amp; Kwan, J. Y. (2016). Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype. Neuroimage Clin, 12, 1035&#x2013;1043. https://doi.org/10.1016/j.nicl.2016.10.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.10.014</ArticleId><ArticleId IdType="pubmed">27995069</ArticleId><ArticleId IdType="pmc">5153604</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter, M. K., Traynor, B. J., Farren, J., Braun, L. E., Tierney, M., Wiggs, E. A., &amp; Wu, T. (2017). Disease progression in C9orf72 mutation carriers. Neurology, 89(3), 234&#x2013;241. https://doi.org/10.1212/wnl.0000000000004115 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000004115</ArticleId><ArticleId IdType="pubmed">28615433</ArticleId><ArticleId IdType="pmc">5513817</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter, M. K., Danielian, L. E., Braun, L. E., &amp; Wu, T. (2018). Longitudinal diffusion imaging across the C9orf72 clinical spectrum. Journal of Neurology, Neurosurgery, and Psychiatry, 89(1), 53&#x2013;60. https://doi.org/10.1136/jnnp-2017-316799 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316799</ArticleId><ArticleId IdType="pubmed">29054917</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris, G., Borghero, G., Cannas, A., Di Stefano, F., Ruiu, E., Murru, M. R., et al. (2015). Constructional apraxia in frontotemporal dementia associated with the C9orf72 mutation: Broadening the clinical and neuropsychological phenotype. Amyotroph Lateral Scler Frontotemporal Degener, 16(1&#x2013;2), 8&#x2013;15. https://doi.org/10.3109/21678421.2014.959450 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959450</ArticleId><ArticleId IdType="pubmed">25285776</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli, G. G., Basilico, P., Arighi, A., Bocchetta, M., Dick, K. M., Cash, D. M., et al. (2018). Distinct patterns of brain atrophy in Genetic frontotemporal dementia Initiative (GENFI) cohort revealed by visual rating scales. Alzheimer&#x2019;s Research &amp; Therapy, 10(1), 46. https://doi.org/10.1186/s13195-018-0376-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0376-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraudie, A., Guerrier, L., Le Ber, I., Clot, F., Peran, P., &amp; Pariente, J. (2020). Atypical clinical presentation and typical FTD atrophy: 17-year clinical follow-up and MRI analysis of a slowly progressive bvFTD associated with C9orf72 expansion. Revue Neurologique (Paris). https://doi.org/10.1016/j.neurol.2020.02.003 .</Citation></Reference><Reference><Citation>Geser, F., Prvulovic, D., O'Dwyer, L., Hardiman, O., Bede, P., Bokde, A. L., et al. (2011). On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Progress in Neurobiology, 95(4), 649&#x2013;662. https://doi.org/10.1016/j.pneurobio.2011.08.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.08.011</ArticleId><ArticleId IdType="pubmed">21911035</ArticleId><ArticleId IdType="pmc">3230745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges, M., Vercruysse, P., Muller, H. P., Huppertz, H. J., Rosenbohm, A., Nagel, G., et al. (2017). Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 88(12), 1033&#x2013;1041. https://doi.org/10.1136/jnnp-2017-315795 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund, V., Pradat, P. F., Querin, G., Delbot, F., Le Chat, G., Pradat-Peyre, J. F., &amp; Bede, P. (2019). Machine learning in Amyotrophic Lateral Sclerosis: Achievements, pitfalls, and future directions. Frontiers in Neuroscience, 13, 135. https://doi.org/10.3389/fnins.2019.00135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId><ArticleId IdType="pmc">6403867</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund, V., Chat, G. L., Secchi-Buhour, M. S., Delbot, F., Pradat-Peyre, J. F., Bede, P., &amp; Pradat, P. F. (2020a). Development and validation of a 1-year survival prognosis estimation model for Amyotrophic Lateral Sclerosis using manifold learning algorithm UMAP. Scientific Reports, 10(1), 13378. https://doi.org/10.1038/s41598-020-70125-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70125-8</ArticleId><ArticleId IdType="pubmed">32770027</ArticleId><ArticleId IdType="pmc">7414917</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund, V., Le Chat, G., Secchi-Buhour, M, S., Delbot, F., Pradat-Peyre, J, F., Bede, P., &amp; Pradat, P, F. (2020b). Manifold learning for amyotrophic lateral sclerosis functional loss assessment : Development and validation of a prognosis model. Journal of Neurology. https://doi.org/10.1007/s00415-020-10181-2 .</Citation></Reference><Reference><Citation>Hsiung, G. Y., DeJesus-Hernandez, M., Feldman, H. H., Sengdy, P., Bouchard-Kerr, P., Dwosh, E., et al. (2012). Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain, 135(Pt 3), 709&#x2013;722. https://doi.org/10.1093/brain/awr354 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr354</ArticleId><ArticleId IdType="pubmed">22344582</ArticleId><ArticleId IdType="pmc">3286328</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli, A., Al Khleifat, A., Jones, A. R., Sproviero, W., Shatunov, A., Opie-Martin, S., et al. (2019). C9orf72 intermediate expansions of 24-30 repeats are associated with ALS. Acta Neuropathologica Communications, 7(1), 115. https://doi.org/10.1186/s40478-019-0724-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId><ArticleId IdType="pmc">6637621</ArticleId></ArticleIdList></Reference><Reference><Citation>Irish, M., Devenney, E., Wong, S., Dobson-Stone, C., Kwok, J. B., Piguet, O., et al. (2013). Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Neuroimage Clin, 2, 836&#x2013;843. https://doi.org/10.1016/j.nicl.2013.06.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2013.06.005</ArticleId><ArticleId IdType="pubmed">24179835</ArticleId><ArticleId IdType="pmc">3778250</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin, D. J., McMillan, C. T., Brettschneider, J., Libon, D. J., Powers, J., Rascovsky, K., et al. (2013). Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 84(2), 163&#x2013;169. https://doi.org/10.1136/jnnp-2012-303507 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiskoot, L. C., Bocchetta, M., Nicholas, J. M., Cash, D. M., Thomas, D., Modat, M., et al. (2018). Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study. Annals of Clinical Translational Neurology, 5(9), 1025&#x2013;1036. https://doi.org/10.1002/acn3.601 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.601</ArticleId><ArticleId IdType="pubmed">30250860</ArticleId><ArticleId IdType="pmc">6144447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek, J., Muller, H. P., Del Tredici, K., Brettschneider, J., Pinkhardt, E. H., Lule, D., et al. (2014). Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain, 137(Pt 6), 1733&#x2013;1740. https://doi.org/10.1093/brain/awu090 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu090</ArticleId><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz, A., Ang, L. C., Jesso, S., MacKinley, J., Baker, M., Brown, P., et al. (2013). Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: A detailed clinical cohort. Cognitive and Behavioral Neurology, 26(3), 146&#x2013;154. https://doi.org/10.1097/wnn.0000000000000008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wnn.0000000000000008</ArticleId><ArticleId IdType="pubmed">24077574</ArticleId><ArticleId IdType="pmc">4090685</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., Fong, J. C., et al. (2012). Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. Journal of Neurology, Neurosurgery, and Psychiatry, 83(4), 358&#x2013;364. https://doi.org/10.1136/jnnp-2011-301883 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301883</ArticleId><ArticleId IdType="pubmed">22399793</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi, B., LaClair, K. D., Riemenschneider, H., Zhou, Q., Frottin, F., Mareljic, N., et al. (2020). Cell-to-cell transmission of C9orf72 poly-(Gly-ala) triggers key features of ALS/FTD. Embo Journal, 39(8), e102811. https://doi.org/10.15252/embj.2019102811 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan, M. C., Ziemann, U., &amp; Eisen, A. (2019). Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period. Muscle &amp; Nerve, 60(3), 232&#x2013;235. https://doi.org/10.1002/mus.26617 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan, J. Y., Jeong, S. Y., Van Gelderen, P., Deng, H. X., Quezado, M. M., Danielian, L. E., et al. (2012). Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: Correlating 7 tesla MRI and pathology. PLoS One, 7(4), e35241. https://doi.org/10.1371/journal.pone.0035241 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId><ArticleId IdType="pmc">3328441</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Blanc, G., Jette Pomerleau, V., McCarthy, J., Borroni, B., van Swieten, J., Galimberti, D., ... Initiative, G. E. F. d (2020). Faster cortical thinning and surface area loss in Presymptomatic and symptomatic C9orf72 repeat expansion adult carriers. Annals of Neurology. https://doi.org/10.1002/ana.25748 .</Citation></Reference><Reference><Citation>Lee, S. E., Khazenzon, A. M., Trujillo, A. J., Guo, C. C., Yokoyama, J. S., Sha, S. J., et al. (2014). Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain, 137(Pt 11), 3047&#x2013;3060. https://doi.org/10.1093/brain/awu248 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu248</ArticleId><ArticleId IdType="pubmed">25273996</ArticleId><ArticleId IdType="pmc">4208465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. E., Sias, A. C., Mandelli, M. L., Brown, J. A., Brown, A. B., Khazenzon, A. M., et al. (2017). Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin, 14, 286&#x2013;297. https://doi.org/10.1016/j.nicl.2016.12.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.12.006</ArticleId><ArticleId IdType="pubmed">28337409</ArticleId></ArticleIdList></Reference><Reference><Citation>Llamas-Velasco, S., Garc&#xed;a-Redondo, A., Herrero-San Mart&#xed;n, A., Puertas Mart&#xed;n, V., Gonz&#xe1;lez-S&#xe1;nchez, M., P&#xe9;rez-Mart&#xed;nez, D. A., &amp; Villarejo-Galende, A. (2018). Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature. Neurocase, 24(1), 68&#x2013;71. https://doi.org/10.1080/13554794.2018.1428353 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554794.2018.1428353</ArticleId><ArticleId IdType="pubmed">29355451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth, C. (2011). Clinical phenomenology and neuroimaging correlates in ALS-FTD. Journal of Molecular Neuroscience, 45(3), 656&#x2013;662. https://doi.org/10.1007/s12031-011-9636-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9636-x</ArticleId><ArticleId IdType="pubmed">21971978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons, A., Higginbottom, A., Cooper-Knock, J., Alrafiah, A., Alofi, E., Kirby, J., ... Highley, J, R. (2020). Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. The Journal of Pathology doi: https://doi.org/10.1002/path.5455 .</Citation></Reference><Reference><Citation>Lucidi, G., Berti, V., Piaceri, I., Ginestroni, A., Lombardi, G., Ferrari, C., et al. (2019). Clinical and neuroimaging profiles to identify. C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease., 7(6), 326&#x2013;333.</Citation></Reference><Reference><Citation>Lule, D., Pauli, S., Altintas, E., Singer, U., Merk, T., Uttner, I., et al. (2012). Emotional adjustment in amyotrophic lateral sclerosis (ALS). Journal of Neurology, 259(2), 334&#x2013;341. https://doi.org/10.1007/s00415-011-6191-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6191-x</ArticleId><ArticleId IdType="pubmed">21808983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9;, D, E., M&#xfc;ller, H, P., Finsel, J., Weydt, P., Knehr, A., Winroth, I., ... Ludolph, A, C. (2020). Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder. Journal of Neurology, Neurosurgery, and Psychiatry doi: https://doi.org/10.1136/jnnp-2020-323671 .</Citation></Reference><Reference><Citation>Ly, C. V., Koenig, L., Christensen, J., Gordon, B., Beaumont, H., Dahiya, S., et al. (2019). Tau positron emission tomography imaging in C9orf72 repeat expansion carriers. European Journal of Neurology, 26(9), 1235&#x2013;1239. https://doi.org/10.1111/ene.13940 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13940</ArticleId><ArticleId IdType="pubmed">30790403</ArticleId><ArticleId IdType="pmc">6684398</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts, J., Loewe, K., Kaufmann, J., Jakubiczka, S., Abdulla, S., Petri, S., et al. (2015). Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology, 85(15), 1301&#x2013;1309. https://doi.org/10.1212/wnl.0000000000002017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000002017</ArticleId><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I. R., &amp; Neumann, M. (2020). Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathologica, 139(1), 83&#x2013;98. https://doi.org/10.1007/s00401-019-02070-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02070-4</ArticleId><ArticleId IdType="pubmed">31501924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., et al. (2013). Dipeptide repeat protein pathology in C9ORF72 mutation cases: Clinico-pathological correlations. Acta Neuropathologica, 126(6), 859&#x2013;879. https://doi.org/10.1007/s00401-013-1181-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney, C. J., Beck, J., Rohrer, J. D., Lashley, T., Mok, K., Shakespeare, T., et al. (2012a). Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: Clinical, neuroanatomical and neuropathological features. Brain, 135(Pt 3), 736&#x2013;750. https://doi.org/10.1093/brain/awr361 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr361</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId><ArticleId IdType="pmc">3286330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney, C. J., Downey, L. E., Ridgway, G. R., Beck, J., Clegg, S., Blair, M., et al. (2012b). Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimer's Research &amp; Therapy, 4(5), 41. https://doi.org/10.1186/alzrt144 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt144</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney, C. J., Simpson, I. J., Nicholas, J. M., Fletcher, P. D., Downey, L. E., Golden, H. L., et al. (2015). Longitudinal diffusion tensor imaging in frontotemporal dementia. Annals of Neurology, 77(1), 33&#x2013;46. https://doi.org/10.1002/ana.24296 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24296</ArticleId><ArticleId IdType="pubmed">25363208</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., et al. (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurology, 11(4), 323&#x2013;330. https://doi.org/10.1016/s1474-4422(12)70043-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(12)70043-1</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>McMackin, R., Bede, P., Pender, N., Hardiman, O., &amp; Nasseroleslami, B. (2019). Neurophysiological markers of network dysfunction in neurodegenerative diseases. Neuroimage Clin, 22, 101706. https://doi.org/10.1016/j.nicl.2019.101706 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101706</ArticleId><ArticleId IdType="pubmed">30738372</ArticleId><ArticleId IdType="pmc">6370863</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan, C. T., Russ, J., Wood, E. M., Irwin, D. J., Grossman, M., McCluskey, L., et al. (2015). C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology, 84(16), 1622&#x2013;1630. https://doi.org/10.1212/WNL.0000000000001495 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001495</ArticleId><ArticleId IdType="pubmed">25795648</ArticleId><ArticleId IdType="pmc">4409587</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier, J. M., van der Burgh, H. K., Nitert, A. D., Bede, P., de Lange, S. C., Hardiman, O., et al. (2020). Connectome-based propagation model in Amyotrophic Lateral Sclerosis. Annals of Neurology, 87(5), 725&#x2013;738. https://doi.org/10.1002/ana.25706 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25706</ArticleId><ArticleId IdType="pubmed">32072667</ArticleId><ArticleId IdType="pmc">7186838</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke, R. A., Proudfoot, M., Wuu, J., Andersen, P. M., Talbot, K., Benatar, M., &amp; Turner, M. R. (2016). Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 580&#x2013;588. https://doi.org/10.1136/jnnp-2015-311945 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311945</ArticleId><ArticleId IdType="pubmed">26733601</ArticleId></ArticleIdList></Reference><Reference><Citation>Montembeault, M., Sayah, S., Rinaldi, D., Le Toullec, B., Bertrand, A., Funkiewiez, A., et al. (2020). Cognitive inhibition impairments in presymptomatic C9orf72 carriers. Journal of Neurology, Neurosurgery, and Psychiatry, 91(4), 366&#x2013;372. https://doi.org/10.1136/jnnp-2019-322242 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322242</ArticleId><ArticleId IdType="pubmed">32054668</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, K. M., Nicholas, J., Grossman, M., McMillan, C. T., Irwin, D. J., Massimo, L., et al. (2020). Age at symptom onset and death and disease duration in genetic frontotemporal dementia: An international retrospective cohort study. Lancet Neurology, 19(2), 145&#x2013;156. https://doi.org/10.1016/s1474-4422(19)30394-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(19)30394-1</ArticleId><ArticleId IdType="pubmed">31810826</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller, H. P., Turner, M. R., Grosskreutz, J., Abrahams, S., Bede, P., Govind, V., et al. (2016). A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 570&#x2013;579. https://doi.org/10.1136/jnnp-2015-311952 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311952</ArticleId><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller, H. P., Agosta, F., Gorges, M., Kassubek, R., Spinelli, E. G., Riva, N., et al. (2018). Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-Centre tract of interest-based DTI analysis. Neuroimage Clin, 20, 1062&#x2013;1069. https://doi.org/10.1016/j.nicl.2018.10.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.10.005</ArticleId><ArticleId IdType="pubmed">30343251</ArticleId><ArticleId IdType="pmc">6198122</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller, H, P., Del Tredici, K., Lul&#xe9;, D., M&#xfc;ller, K., Weishaupt, J, H., Ludolph, A, C., &amp; Kassubek, J. (2020). In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study. Neuroimage Clinical, 27, 102298. https://doi.org/10.1016/j.nicl.2020.102298 .</Citation></Reference><Reference><Citation>Murray, M. E., DeJesus-Hernandez, M., Rutherford, N. J., Baker, M., Duara, R., Graff-Radford, N. R., et al. (2011). Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathologica, 122(6), 673&#x2013;690. https://doi.org/10.1007/s00401-011-0907-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0907-y</ArticleId><ArticleId IdType="pubmed">22083254</ArticleId><ArticleId IdType="pmc">3277860</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutsaerts, H., Mirza, S. S., Petr, J., Thomas, D. L., Cash, D. M., Bocchetta, M., et al. (2019). Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study. Brain, 142(4), 1108&#x2013;1120. https://doi.org/10.1093/brain/awz039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz039</ArticleId><ArticleId IdType="pubmed">30847466</ArticleId><ArticleId IdType="pmc">6439322</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasseroleslami, B., Dukic, S., Broderick, M., Mohr, K., Schuster, C., Gavin, B., et al. (2019). Characteristic increases in EEG connectivity correlate with changes of structural MRI in Amyotrophic Lateral Sclerosis. Cerebral Cortex, 29(1), 27&#x2013;41. https://doi.org/10.1093/cercor/bhx301 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhx301</ArticleId><ArticleId IdType="pubmed">29136131</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble, K. G., Grieve, S. M., Korgaonkar, M. S., Engelhardt, L. E., Griffith, E. Y., Williams, L. M., &amp; Brickman, A. M. (2012). Hippocampal volume varies with educational attainment across the life-span. Frontiers in Human Neuroscience, 6, 307. https://doi.org/10.3389/fnhum.2012.00307 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2012.00307</ArticleId><ArticleId IdType="pubmed">23162453</ArticleId><ArticleId IdType="pmc">3494123</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney, N. T., Ong, E., Goh, S. M., Bajorek, L., Dever, R., Staffaroni, A. M., et al. (2020). Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement, 16(1), 49&#x2013;59. https://doi.org/10.1016/j.jalz.2019.08.196 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.08.196</ArticleId><ArticleId IdType="pubmed">31784375</ArticleId><ArticleId IdType="pmc">6988137</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer, T., Finegan, E., Hutchinson, S., Doherty, M., Vajda, A., McLaughlin, R. L., et al. (2017). Neuroimaging patterns along the ALS-FTD spectrum: A multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener, 18(7&#x2013;8), 611&#x2013;623. https://doi.org/10.1080/21678421.2017.1332077 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1332077</ArticleId><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallebage-Gamarallage, M., Foxley, S., Menke, R. A. L., Huszar, I. N., Jenkinson, M., Tendler, B. C., et al. (2018). Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. BMC Neuroscience, 19(1), 11. https://doi.org/10.1186/s12868-018-0416-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-018-0416-1</ArticleId><ArticleId IdType="pubmed">29529995</ArticleId><ArticleId IdType="pmc">5848544</ArticleId></ArticleIdList></Reference><Reference><Citation>Panman, J. L., Jiskoot, L. C., Bouts, M., Meeter, L. H. H., van der Ende, E. L., Poos, J. M., et al. (2019). Gray and white matter changes in presymptomatic genetic frontotemporal dementia: A longitudinal MRI study. Neurobiology of Aging, 76, 115&#x2013;124. https://doi.org/10.1016/j.neurobiolaging.2018.12.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.017</ArticleId><ArticleId IdType="pubmed">30711674</ArticleId></ArticleIdList></Reference><Reference><Citation>Papma, J. M., Jiskoot, L. C., Panman, J. L., Dopper, E. G., den Heijer, T., Donker Kaat, L., et al. (2017). Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology, 89(12), 1256&#x2013;1264. https://doi.org/10.1212/wnl.0000000000004393 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000004393</ArticleId><ArticleId IdType="pubmed">28855404</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliner, H. A., Mann, D. M., &amp; Traynor, B. J. (2014). Searching for Grendel: Origin and global spread of the C9ORF72 repeat expansion. Acta Neuropathologica, 127(3), 391&#x2013;396. https://doi.org/10.1007/s00401-014-1250-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1250-x</ArticleId><ArticleId IdType="pubmed">24496499</ArticleId><ArticleId IdType="pmc">4545603</ArticleId></ArticleIdList></Reference><Reference><Citation>Popuri, K., Dowds, E., Beg, M. F., Balachandar, R., Bhalla, M., Jacova, C., et al. (2018). Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers. Neuroimage Clin, 18, 591&#x2013;598. https://doi.org/10.1016/j.nicl.2018.02.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.02.017</ArticleId><ArticleId IdType="pubmed">29845007</ArticleId><ArticleId IdType="pmc">5964622</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell, T., &amp; Grosskreutz, J. (2013). The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(7&#x2013;8), 507&#x2013;515. https://doi.org/10.3109/21678421.2013.812661 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Premi, E., Calhoun, V. D., Diano, M., Gazzina, S., Cosseddu, M., Alberici, A., et al. (2019). The inner fluctuations of the brain in presymptomatic frontotemporal dementia: The chronnectome fingerprint. Neuroimage, 189, 645&#x2013;654. https://doi.org/10.1016/j.neuroimage.2019.01.080 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2019.01.080</ArticleId><ArticleId IdType="pubmed">30716457</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot, M., Rohenkohl, G., Quinn, A., Colclough, G. L., Wuu, J., Talbot, K., et al. (2017). Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Human Brain Mapping, 38(1), 237&#x2013;254. https://doi.org/10.1002/hbm.23357 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23357</ArticleId><ArticleId IdType="pubmed">27623516</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot, M., Bede, P., &amp; Turner, M. R. (2018). Imaging cerebral activity in Amyotrophic Lateral Sclerosis. Frontiers in Neurology, 9, 1148. https://doi.org/10.3389/fneur.2018.01148 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01148</ArticleId><ArticleId IdType="pubmed">30671016</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaegebeur, A., Glaria, I., Lashley, T., &amp; Isaacs, A. M. (2020). Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity. Acta Neuropathologica Communications, 8(1), 184. https://doi.org/10.1186/s40478-020-01036-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01036-y</ArticleId><ArticleId IdType="pubmed">33168090</ArticleId><ArticleId IdType="pmc">7650212</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin, G., Bede, P., El Mendili, M, M., Li, M., Pelegrini-Issac, M., Rinaldi, D., ... Amyotrophic Lateral Sclerosis Study, G (2019). Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study. Annals of Neurology. https://doi.org/10.1002/ana.25520 .</Citation></Reference><Reference><Citation>Rascovsky, K., &amp; Grossman, M. (2013). Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration. International Review of Psychiatry, 25(2), 145&#x2013;158. https://doi.org/10.3109/09540261.2013.763341 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.763341</ArticleId><ArticleId IdType="pubmed">23611345</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A. E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J. R., et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72(2), 257&#x2013;268. https://doi.org/10.1016/j.neuron.2011.09.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku, Y. (2020). Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology, 40(5), 426&#x2013;435. https://doi.org/10.1111/neup.12644 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12644</ArticleId><ArticleId IdType="pubmed">32157757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittman, T., Borchert, R., Jones, S., van Swieten, J., Borroni, B., Galimberti, D., et al. (2019). Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia. Neurobiology of Aging, 77, 169&#x2013;177. https://doi.org/10.1016/j.neurobiolaging.2018.12.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.009</ArticleId><ArticleId IdType="pubmed">30831384</ArticleId><ArticleId IdType="pmc">6491498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., et al. (2015a). C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurology, 14(3), 291&#x2013;301. https://doi.org/10.1016/S1474-4422(14)70233-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70233-9</ArticleId><ArticleId IdType="pubmed">25638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., et al. (2015b). Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis. Lancet Neurology, 14(3), 253&#x2013;262. https://doi.org/10.1016/s1474-4422(14)70324-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(14)70324-2</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney, J., Murray, D., Campion, A., Moloney, H., Tattersall, R., Doherty, M., et al. (2019). The C9orf72 expansion is associated with accelerated respiratory function decline in a large Amyotrophic Lateral Sclerosis cohort. HRB Open Res, 2, 23. https://doi.org/10.12688/hrbopenres.12940.1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.12940.1</ArticleId><ArticleId IdType="pubmed">32296747</ArticleId><ArticleId IdType="pmc">7140774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rytty, R., Nikkinen, J., Suhonen, N., Moilanen, V., Renton, A., Traynor, B., &amp; J., et al. (2014). Functional MRI in patients with the C9ORF72 expansion associate frontotemporal dementia. Molecular Biology, 3, 117. https://doi.org/10.4172/2168-9547.1000117 .</Citation></Reference><Reference><Citation>Schludi, M. H., May, S., Grasser, F. A., Rentzsch, K., Kremmer, E., Kupper, C., et al. (2015). Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathologica, 130(4), 537&#x2013;555. https://doi.org/10.1007/s00401-015-1450-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId><ArticleId IdType="pmc">4575390</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonecker, S., Neuhofer, C., Otto, M., Ludolph, A., Kassubek, J., Landwehrmeyer, B., et al. (2018). Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients - an atlas-based volumetric MRI Study. Frontiers in Aging Neuroscience, 10, 45. https://doi.org/10.3389/fnagi.2018.00045 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00045</ArticleId><ArticleId IdType="pubmed">29599716</ArticleId><ArticleId IdType="pmc">5863593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster, C., Elamin, M., Hardiman, O., &amp; Bede, P. (2015). Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: A systematic review. Journal of Neurology, Neurosurgery, and Psychiatry, 86(10), 1089&#x2013;1096. https://doi.org/10.1136/jnnp-2014-309888 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309888</ArticleId><ArticleId IdType="pubmed">25632156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster, C., Elamin, M., Hardiman, O., &amp; Bede, P. (2016a). The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. European Journal of Neurology, 23(8), 1361&#x2013;1371. https://doi.org/10.1111/ene.13038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13038</ArticleId><ArticleId IdType="pubmed">27207250</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster, C., Hardiman, O., &amp; Bede, P. (2016b). Development of an automated MRI-based diagnostic protocol for Amyotrophic Lateral Sclerosis using disease-specific pathognomonic features: A quantitative disease-state classification Study. PLoS One, 11(12), e0167331. https://doi.org/10.1371/journal.pone.0167331 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167331</ArticleId><ArticleId IdType="pubmed">27907080</ArticleId><ArticleId IdType="pmc">5132189</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster, C., Hardiman, O., &amp; Bede, P. (2017). Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurology, 17(1), 73. https://doi.org/10.1186/s12883-017-0854-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId><ArticleId IdType="pmc">5393027</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellami, L., Bocchetta, M., Masellis, M., Cash, D. M., Dick, K. M., van Swieten, J., et al. (2018). Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three Main forms of Genetic frontotemporal dementia in the GENFI cohort. Journal of Alzheimer's Disease, 65(1), 147&#x2013;163. https://doi.org/10.3233/jad-180053 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-180053</ArticleId><ArticleId IdType="pubmed">30010122</ArticleId><ArticleId IdType="pmc">6087430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellami, L., St-Onge, F., Poulin, S., &amp; Laforce Jr., R. (2019). Schizophrenia phenotype preceding behavioral variant frontotemporal dementia related to C9orf72 repeat expansion. Cognitive and Behavioral Neurology, 32(2), 120&#x2013;123. https://doi.org/10.1097/wnn.0000000000000189 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wnn.0000000000000189</ArticleId><ArticleId IdType="pubmed">31205123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha, S. J., Takada, L. T., Rankin, K. P., Yokoyama, J. S., Rutherford, N. J., Fong, J. C., et al. (2012). Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology, 79(10), 1002&#x2013;1011. https://doi.org/10.1212/WNL.0b013e318268452e .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318268452e</ArticleId><ArticleId IdType="pubmed">22875087</ArticleId><ArticleId IdType="pmc">3430713</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon-Sanchez, J., Dopper, E. G., Cohn-Hokke, P. E., Hukema, R. K., Nicolaou, N., Seelaar, H., et al. (2012). The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain, 135(Pt 3), 723&#x2013;735. https://doi.org/10.1093/brain/awr353 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr353</ArticleId><ArticleId IdType="pubmed">22300876</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, R., Santillo, A. F., Waldo, M. L., Strandberg, O., Berron, D., Vestberg, S., et al. (2019). (18)F-Flortaucipir in TDP-43 associated frontotemporal dementia. Sci Rep, 9(1), 6082. https://doi.org/10.1038/s41598-019-42625-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42625-9</ArticleId><ArticleId IdType="pubmed">30988363</ArticleId><ArticleId IdType="pmc">6465310</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M., et al. (2012). Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain, 135(Pt 3), 693&#x2013;708. https://doi.org/10.1093/brain/awr355 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr355</ArticleId><ArticleId IdType="pubmed">22300873</ArticleId><ArticleId IdType="pmc">3286329</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker, P., Feneberg, E., Weishaupt, J., Brettschneider, J., Tumani, H., Andersen, P. M., et al. (2016). Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients. Journal of Neurology, Neurosurgery, and Psychiatry, 87(1), 12&#x2013;20. https://doi.org/10.1136/jnnp-2015-311387 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311387</ArticleId><ArticleId IdType="pubmed">26296871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre, C. H., Bocchetta, M., Cash, D., Thomas, D. L., Woollacott, I., Dick, K. M., et al. (2017). White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. Neuroimage Clin, 15, 171&#x2013;180. https://doi.org/10.1016/j.nicl.2017.04.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.04.015</ArticleId><ArticleId IdType="pubmed">28529873</ArticleId><ArticleId IdType="pmc">5429247</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhonen, N. M., Kaivorinne, A. L., Moilanen, V., Bode, M., Takalo, R., H&#xe4;nninen, T., &amp; Remes, A. M. (2015). Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: A 20-year follow-up study. Neurocase, 21(1), 85&#x2013;89. https://doi.org/10.1080/13554794.2013.873057 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554794.2013.873057</ArticleId><ArticleId IdType="pubmed">24417314</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen, B., &amp; Robberecht, W. (2014). The phenotypic variability of amyotrophic lateral sclerosis. Nature Reviews. Neurology, 10(11), 661&#x2013;670. https://doi.org/10.1038/nrneurol.2014.184 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, R. H., Devenney, E., Dobson-Stone, C., Kwok, J. B., Hodges, J. R., Kiernan, M. C., et al. (2014). Cerebellar integrity in the amyotrophic lateral sclerosis - frontotemporal dementia continuum. PLoS One, 9(8), e105632. https://doi.org/10.1371/journal.pone.0105632 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105632</ArticleId><ArticleId IdType="pubmed">25144223</ArticleId><ArticleId IdType="pmc">4140802</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares, T. P., Mitchell, D. G. V., Coleman, K., Shoesmith, C., Bartha, R., Cash, D. M., et al. (2019). Ventricular volume expansion in presymptomatic genetic frontotemporal dementia. Neurology, 93(18), e1699&#x2013;e1706. https://doi.org/10.1212/WNL.0000000000008386 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008386</ArticleId><ArticleId IdType="pubmed">31578297</ArticleId><ArticleId IdType="pmc">6946476</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, L. J., Brown, R. G., Tsermentseli, S., Al-Chalabi, A., Shaw, C. E., Ellis, C. M., et al. (2013). Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? Journal of Neurology, Neurosurgery, and Psychiatry, 84(5), 494&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303526</ArticleId></ArticleIdList></Reference><Reference><Citation>Troakes, C., Maekawa, S., Wijesekera, L., Rogelj, B., Siklos, L., Bell, C., et al. (2012). An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology, 32(5), 505&#x2013;514. https://doi.org/10.1111/j.1440-1789.2011.01286.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01286.x</ArticleId><ArticleId IdType="pubmed">22181065</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi, F., Esposito, F., de Stefano, M., Buonanno, D., Conforti, F. L., Corbo, D., et al. (2015). Functional overlap and divergence between ALS and bvFTD. Neurobiology of Aging, 36(1), 413&#x2013;423. https://doi.org/10.1016/j.neurobiolaging.2014.06.025 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.025</ArticleId><ArticleId IdType="pubmed">25063233</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi, F., Sorrentino, P., Sorrentino, G., &amp; Tedeschi, G. (2017). Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: Evidence from MRI and MEG studies. CNS Spectrums, 1&#x2013;10. https://doi.org/10.1017/s109285291700075x .</Citation></Reference><Reference><Citation>Trojsi, F., Siciliano, M., Femiano, C., Santangelo, G., Lunetta, C., Calvo, A., et al. (2019). Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: The effect of male sex on survival of C9orf72 positive patients. Frontiers in Neuroscience, 13, 485. https://doi.org/10.3389/fnins.2019.00485 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00485</ArticleId><ArticleId IdType="pubmed">31156370</ArticleId><ArticleId IdType="pmc">6534038</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi, F., Di Nardo, F., Caiazzo, G., Siciliano, M., D'Alvano, G., Ferrantino, T., et al. (2020). Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): More than Papez circuit impairment. Brain Imaging and Behavior. https://doi.org/10.1007/s11682-020-00408-1 .</Citation></Reference><Reference><Citation>Turner, M. R., Al-Chalabi, A., Chio, A., Hardiman, O., Kiernan, M. C., Rohrer, J. D., et al. (2017). Genetic screening in sporadic ALS and FTD. Journal of Neurology, Neurosurgery, and Psychiatry, 88(12), 1042&#x2013;1044. https://doi.org/10.1136/jnnp-2017-315995 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315995</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajda, A., McLaughlin, R. L., Heverin, M., Thorpe, O., Abrahams, S., Al-Chalabi, A., &amp; Hardiman, O. (2017). Genetic testing in ALS: A survey of current practices. Neurology, 88(10), 991&#x2013;999. https://doi.org/10.1212/WNL.0000000000003686 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003686</ArticleId><ArticleId IdType="pubmed">28159885</ArticleId><ArticleId IdType="pmc">5333513</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente, E. S., Caramelli, P., Gambogi, L. B., Mariano, L. I., Guimaraes, H. C., Teixeira, A. L., &amp; de Souza, L. C. (2019). Phenocopy syndrome of behavioral variant frontotemporal dementia: A systematic review. Alzheimer's Research &amp; Therapy, 11(1), 30. https://doi.org/10.1186/s13195-019-0483-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0483-2</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh, H. K., Westeneng, H. J., Meier, J. M., van Es, M. A., Veldink, J. H., Hendrikse, J., et al. (2019). Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. Neuroimage Clin, 24, 101984. https://doi.org/10.1016/j.nicl.2019.101984 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101984</ArticleId><ArticleId IdType="pubmed">31499409</ArticleId><ArticleId IdType="pmc">6734179</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh, H. K., Westeneng, H. J., Walhout, R., van Veenhuijzen, K., Tan, H. H. G., Meier, J. M., et al. (2020). Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology. https://doi.org/10.1212/WNL.0000000000009498 .</Citation></Reference><Reference><Citation>Van Laere, K., Vanhee, A., Verschueren, J., De Coster, L., Driesen, A., Dupont, P., et al. (2014). Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: A prospective study. JAMA Neurology, 71(5), 553&#x2013;561. https://doi.org/10.1001/jamaneurol.2014.62 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.62</ArticleId><ArticleId IdType="pubmed">24615479</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove, T., van der Zee, J., Gijselinck, I., Engelborghs, S., Vandenberghe, R., Vandenbulcke, M., et al. (2013). Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurology, 70(3), 365&#x2013;373. https://doi.org/10.1001/2013.jamaneurol.181 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2013.jamaneurol.181</ArticleId><ArticleId IdType="pubmed">23338682</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen, W., van Blitterswijk, M., Huisman, M. H., Vlam, L., van Doormaal, P. T., Seelen, M., et al. (2012). Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology, 79(9), 878&#x2013;882. https://doi.org/10.1212/WNL.0b013e3182661d14 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182661d14</ArticleId><ArticleId IdType="pubmed">22843265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai, S. C., Yoon, S. J., Gardner, R. C., Gendron, T. F., Vargas, J. N., Trujillo, A., et al. (2016). Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain, 139(Pt 12), 3202&#x2013;3216. https://doi.org/10.1093/brain/aww250 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww250</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId><ArticleId IdType="pmc">5790143</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout, R., Schmidt, R., Westeneng, H. J., Verstraete, E., Seelen, M., van Rheenen, W., et al. (2015). Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers. Neurology, 85(20), 1780&#x2013;1788. https://doi.org/10.1212/wnl.0000000000002135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000002135</ArticleId><ArticleId IdType="pubmed">26497991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen, J., Zhang, H., Alexander, D. C., Durrleman, S., Routier, A., Rinaldi, D., et al. (2019). Neurite density is reduced in the presymptomatic phase of C9orf72 disease. Journal of Neurology, Neurosurgery, and Psychiatry, 90(4), 387&#x2013;394. https://doi.org/10.1136/jnnp-2018-318994 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318994</ArticleId><ArticleId IdType="pubmed">30355607</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng, H. J., Walhout, R., Straathof, M., Schmidt, R., Hendrikse, J., Veldink, J. H., et al. (2016). Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. Journal of Neurology, Neurosurgery, and Psychiatry, 87(12), 1354&#x2013;1360. https://doi.org/10.1136/jnnp-2016-313959 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313959</ArticleId><ArticleId IdType="pubmed">27756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng, H.-J., Wismans, C., Nitert, A. D., Walhout, R., Luijten, P. R., Wijnen, J. P., &amp; van den Berg, L. H. (2017). Metabolic differences between asymptomatic C9orf72 carriers and non-carriers assessed by brain 7T MRSI. Honolulu, USA: Paper presented at the proceedings of the 25th annual meeting of ISMRM.</Citation></Reference><Reference><Citation>Westergard, T., Jensen, B. K., Wen, X., Cai, J., Kropf, E., Iacovitti, L., et al. (2016). Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Reports, 17(3), 645&#x2013;652. https://doi.org/10.1016/j.celrep.2016.09.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell, J. L., Weigand, S. D., Boeve, B. F., Senjem, M. L., Gunter, J. L., DeJesus-Hernandez, M., et al. (2012). Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain, 135(Pt 3), 794&#x2013;806. https://doi.org/10.1093/brain/aws001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws001</ArticleId><ArticleId IdType="pubmed">22366795</ArticleId><ArticleId IdType="pmc">3286334</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell, J. L., Boeve, B. F., Weigand, S. D., Senjem, M. L., Gunter, J. L., Baker, M. C., et al. (2015). Brain atrophy over time in genetic and sporadic frontotemporal dementia: A study of 198 serial magnetic resonance images. European Journal of Neurology, 22(5), 745&#x2013;752. https://doi.org/10.1111/ene.12675 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12675</ArticleId><ArticleId IdType="pubmed">25683866</ArticleId><ArticleId IdType="pmc">4390434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y., Halliday, G. M., Hodges, J. R., &amp; Tan, R. H. (2017). von Economo neuron density and thalamus volumes in behavioral deficits in frontotemporal dementia cases with and without a C9ORF72 repeat expansion. Journal of Alzheimer&#x2019;s Disease, 58(3), 701&#x2013;709. https://doi.org/10.3233/jad-170002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-170002</ArticleId><ArticleId IdType="pubmed">28482638</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova, Y., Plowman, E. K., Green, J. R., Barnett, C., &amp; Bede, P. (2019). Clinical measures of bulbar dysfunction in ALS. Frontiers in Neurology, 10, 106. https://doi.org/10.3389/fneur.2019.00106 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00106</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId><ArticleId IdType="pmc">6389633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>